Sun Pharma

Sun Pharma to Acquire Checkpoint Therapeutics

Indian generic drug maker Sun Pharma agreed to acquire US immunotherapy and targeted oncology company Checkpoint Therapeutics for an upfront value of $355 million. The transaction is expected to be completed in the second quarter of 2025 and is subject to customary closing conditions.

Sun Pharma Sells US Plants to Frontida

Sun Pharma Buys Novartis Drugs

Mylan to Buy Sweden’s Meda for $9.9 Billion

Teva, Sun Pharma to Pay $2.15 Billion to Settle Pfizer Patent Suit

India's Sun Pharma in Talks to Buy Sweden's Meda for $5-$6 Billion

India's Sun Pharma Wins over Taro with Higher Offer

India's Sun Pharma, US Merck in Generics Joint Venture